Substance P promotes immunotherapy efficacy for airway allergy()

BACKGROUND: Allergen-specific immunotherapy (AIT) has been employed in the treatment of allergic diseases for many years. However, the effectiveness of AIT requires improvement. Substance P (SP) can interact with immune cells, modulate immune cell activity, and regulate immune reaction. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yongjin, Liu, Yu, Wang, Xinxin, Liu, Huazhen, Wu, Gaohui, Yang, Liteng, Guan, Li, Huang, Qinmiao, Zeng, Xianhai, Yang, Pingchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Full-Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791926/
https://www.ncbi.nlm.nih.gov/pubmed/36601262
http://dx.doi.org/10.1016/j.waojou.2022.100730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791926/
https://www.ncbi.nlm.nih.gov/pubmed/36601262
http://dx.doi.org/10.1016/j.waojou.2022.100730

Ejemplares similares